GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Ultralife Corp (NAS:ULBI) » Definitions » Change In Receivables

Ultralife (Ultralife) Change In Receivables : $-3.9 Mil (TTM As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Ultralife Change In Receivables?

Ultralife's change in receivables for the quarter that ended in Dec. 2023 was $-4.5 Mil. It means Ultralife's Accounts Receivable increased by $4.5 Mil from Sep. 2023 to Dec. 2023 .

Ultralife's change in receivables for the fiscal year that ended in Dec. 2023 was $-3.9 Mil. It means Ultralife's Accounts Receivable increased by $3.9 Mil from Dec. 2022 to Dec. 2023 .

Ultralife's Accounts Receivable for the quarter that ended in Dec. 2023 was $31.8 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Ultralife's Days Sales Outstanding for the three months ended in Dec. 2023 was 65.06.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ultralife's liquidation value for the three months ended in Dec. 2023 was $2.3 Mil.


Ultralife Change In Receivables Historical Data

The historical data trend for Ultralife's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultralife Change In Receivables Chart

Ultralife Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.42 9.21 4.42 -7.88 -3.89

Ultralife Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.45 3.37 -4.17 1.37 -4.46

Ultralife Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ultralife  (NAS:ULBI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ultralife's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=31.761/44.548*91
=65.06

2. In Ben Graham's calculation of liquidation value, Ultralife's accounts receivable are only considered to be worth 75% of book value:

Ultralife's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=10.196-52.849+0.75 * 31.761+0.5 * 42.215
=2.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ultralife Change In Receivables Related Terms

Thank you for viewing the detailed overview of Ultralife's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Ultralife (Ultralife) Business Description

Traded in Other Exchanges
Address
2000 Technology Parkway, Newark, NY, USA, 14513
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company design, manufacture, install and maintain power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from Battery and Energy Products segment.
Executives
Bradford T Whitmore 10 percent owner 5215 OLD ORCHARD ROAD, SUITE 620, SKOKIE IL 60077
Michael Edward Manna director, officer: President and CEO 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
W. Shaw Robert director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Janie Goddard director C/O ACON - 1133 CONNECTICUT AVENUE, NW, SUITE 700, WASHINGTON DC 20036
Thomas Louis Saeli director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Philip A Fain officer: Vice President C/O CXO ON THE GO OF DELAWARE, LLC, 3349 MONROE AVENUE, # 256, ROCHESTER NY 14618
Michael D Popielec director, officer: President and CEO 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Steven Mark Anderson director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Sunray I, Llc 10 percent owner 1560 SHERMAN AVENUE, SUITE 900, EVANSTON IL 60201
James A. Croce director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Spurgeon Corp 10 percent owner 407 S. THIRD STREET, SUITE 230, GENEVA IL 60134
Patricia C Barron director 6601 WEST BROAD STREET, P O BOX 27003, RICHMOND VA 23261-7003
Daniel W Christman director C/O ENTEGRIS, INC., 129 CONCORD ROAD, BILLERICA MA 01821
Paula H Cholmondeley director 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Ranjit C Singh director